Thalidomide neurotoxicity in dermatological patients: the next "STEP".
Gaspari
Anthony
A
Department of Dermatology, University of Maryland School of Medicine, Baltimore, USA.
D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D009498:Neurotoxins / Q000009:adverse effects; D012871:Skin Diseases / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects*
D003879:Dermatologic Agents; D009498:Neurotoxins; D013792:Thalidomide